CHRONIC: Beta‐blockers vs placebo
All cardiovascular death · heart failure with chronic kidney disease
CHRONIC: Beta‐blockers may leads to lower cardiovascular death ( compared with placebo (low certainty).
1 finding from 1 review
- Pharmacological interventions for heart failure in people with chronic kidney disease 2020 · Cochrane Headline outcomes onlyRR 0.53 [0.35, 0.81]3 studies · 2287 participantsLow